nucleic
acid
aptam
singlestrand
dna
rna
molecul
identifi
recogn
high
affin
specif
target
includ
protein
small
molecul
ion
whole
cell
even
entir
organ
virus
bacteria
identifi
combinatori
librari
dna
rna
oligonucleotid
selex
technolog
vitro
iter
select
procedur
consist
bind
captur
partit
amplif
step
remark
mani
aptam
select
biolog
relev
protein
target
grich
sequenc
fold
stabl
gquadruplex
structur
aim
dissemin
novel
inspir
idea
within
scientif
commun
field
emphasi
review
place
recent
advanc
selex
technolog
effici
rapid
identif
new
candid
aptam
introduct
microfluid
system
next
gener
sequenc
recurr
structur
aptam
select
selex
biolog
relev
protein
target
discoveri
sever
motif
import
regulatori
region
human
viral
genom
bound
endogen
protein
per
se
result
potenti
aptam
updat
overview
aptam
therapeut
potenti
discuss
attract
aptam
diagnost
applic
nucleic
acid
aptam
singlestrand
dna
rna
molecul
gener
base
length
identifi
pool
randomsequ
oligonucleotid
on
vitro
select
process
call
selex
systemat
evolut
ligand
exponenti
enrich
introduc
earli
independ
research
group
gold
szostak
thank
uniqu
threedimension
fold
aptam
recogn
wide
rang
molecular
target
includ
protein
small
molecul
ion
whole
cell
even
entir
organ
virus
bacteria
affin
express
term
dissoci
constant
k
rang
picomolar
pm
micromolar
aptam
adopt
uniqu
subset
structur
defin
combin
basepair
stack
sugar
pucker
well
electrostat
hydrogen
bond
noncanon
intramolecular
interact
structur
complex
result
high
probabl
select
aptam
strongli
specif
interact
target
interest
hydrogen
bond
salt
bridg
van
der
waal
hydrophob
andor
electrostat
interact
high
affin
select
target
well
multipl
possibl
target
type
make
aptam
valid
altern
antibodi
wide
varieti
applic
therapeut
drug
drugdeliveri
system
diagnost
sens
devic
nucleic
acid
aptam
exhibit
signific
advantag
antibodi
smaller
size
lower
immunogen
remark
stabil
wide
rang
ph
temperatur
addit
aptam
allow
easi
control
fold
process
even
prolong
denatur
typic
revers
upon
restor
nativ
condit
addit
select
oligonucleotidebas
aptam
easili
obtain
animalfre
system
chemic
synthesi
allow
also
easili
perform
ad
hoc
tailor
chemic
modif
increas
aptam
chemic
biolog
stabil
bring
product
cost
well
antibodi
mention
aptam
develop
gener
exploit
selex
methodolog
involv
vitro
iter
select
procedur
consist
three
main
step
bind
captur
random
librari
incub
desir
target
molecul
defin
condit
ii
partit
targetbound
aptam
separ
unbound
one
iii
amplif
enrich
pool
select
aptam
amplifi
use
success
round
select
process
best
aptam
select
target
enrich
initi
librari
complex
decreas
fig
left
start
pool
whose
appropri
choic
repres
crucial
point
success
selex
method
contain
dna
rna
singl
strand
intern
random
sequenc
usual
nucleotid
termin
fix
sequenc
complementari
predefin
primer
use
amplif
step
aptam
librari
deriv
chemic
synthesi
genom
dna
transcriptom
sourc
realiz
deoxyribo
ribo
modifi
nucleotid
modifi
nucleotid
primarili
use
increas
chemic
enzymat
stabil
aptam
also
contribut
greatli
broaden
chemic
divers
improv
bind
affin
specif
select
target
among
method
develop
expand
repertoir
nucleobasemodifi
aptam
recent
mayer
et
al
introduc
click
chemistri
protocol
gener
novel
class
modifi
aptam
term
clickmer
fulli
compat
common
step
establish
vitro
select
procedur
clickselex
mani
enzym
read
write
aptam
sequenc
contain
unnatur
nucleotid
avail
method
identifi
precis
locat
nucleotid
within
aptam
sequenc
known
well
valuabl
exampl
modifi
nucleic
acid
use
aptam
product
lock
nucleic
acid
lna
on
sugar
backbon
contain
spiegelm
german
word
spiegel
mirror
highaffin
rnalik
ligand
compos
lribos
unit
highli
resist
nucleas
degrad
due
chirallyinvert
backbon
develop
noxxon
pharma
spiegelm
current
advanc
clinic
trial
somam
slow
offrat
modifi
aptam
develop
somalog
inc
singlestrand
dna
aptam
bear
medctp
basemodifi
du
bndu
napdu
trpdu
ibudu
residu
produc
aptam
significantli
increas
chemic
divers
allow
higher
chanc
select
interact
protein
develop
somam
constitut
highli
multiplex
proteom
platform
use
simultan
identif
quantif
target
protein
complex
biolog
sampl
biomark
discoveri
incub
librari
select
target
partit
bound
unbound
sequenc
obtain
differ
way
fig
right
side
typic
heterogen
method
appli
purpos
filtrat
base
differenti
retent
proteindna
complex
free
dna
membran
ii
affin
chromatographi
protein
immobil
surfac
retain
oligonucleotid
basi
bind
affin
unbound
sequenc
discard
iii
magnet
beadsbas
separ
magnet
separ
employ
partit
unbound
on
beadsbound
targetaptam
complex
surfacebas
techniqu
suffer
nonspecif
adsorpt
free
on
surfac
matrix
reduc
effici
partit
lead
necess
multipl
round
well
neg
select
step
furthermor
immobil
process
use
heterogen
partit
techniqu
neg
affect
protein
structur
potenti
reduc
biolog
relev
select
oligonucleotid
thu
homogen
method
highli
desir
select
aptam
protein
target
especi
case
aptam
develop
therapeut
applic
altern
surfacebas
method
kinet
capillari
electrophoresi
kce
techniqu
describ
effici
system
aptam
select
base
separ
aptamertarget
complex
unbound
on
accord
differ
electrophoret
mobil
electr
field
particular
nonequilibrium
capillari
electrophoresi
equilibrium
mixtur
neceem
wide
use
kce
method
highli
effici
select
aptam
allow
also
accur
calcul
bind
paramet
k
k
k
aptamertarget
interact
effici
partit
neceem
least
order
magnitud
higher
convent
surfacebas
select
techniqu
result
librari
enrich
complet
round
neceembas
selex
contrast
round
typic
requir
selex
base
heterogen
partit
ideal
electr
field
zone
free
dna
dnatarget
complex
free
target
separ
lower
k
valu
time
aptam
spend
within
target
closer
migrat
time
free
target
contrast
higher
k
valu
time
aptam
spend
free
dna
molecul
similar
migrat
time
respect
free
dna
mobil
dnaprotein
complex
typic
intermedi
dna
protein
alon
thu
whole
electropherogram
display
variou
compon
follow
order
free
protein
specif
dnaprotein
complex
low
k
valu
nonspecif
dnaprotein
complex
high
k
valu
free
dna
fraction
collect
approach
capillari
electrophoresi
selex
fceselex
allow
partit
collect
aptamertarget
complex
origin
dna
librari
illustr
fig
ensur
aptam
miss
follow
partit
targetbound
oligonucleotid
elut
target
amplifi
pcr
dna
selex
revers
transcript
pcr
rna
selex
give
enrich
pool
select
oligonucleotid
use
success
selex
round
increasingli
stringent
condit
shorter
incub
time
higher
temperatur
higher
ontarget
ratio
success
round
selex
highaffin
oligonucleotid
enrich
number
year
classic
pcr
amplif
protocol
use
howev
convent
pcr
amplif
method
found
quickli
degrad
product
rapidli
form
byproduct
format
heterodim
addit
dna
amplif
convent
pcr
suscept
nonspecif
primer
hybrid
primer
dimer
amplif
bia
potenti
aptam
loss
due
adhes
wall
pcr
tube
number
approach
propos
year
mend
aforement
ineffici
pcr
amplif
selex
recent
selex
method
combin
neceem
partit
highli
effici
amplif
procedur
term
emuls
pcr
epcr
describ
epcr
allow
compartment
miniatur
pcr
reaction
vitro
vigor
mix
miner
oil
surfact
convent
pcr
mix
creat
local
homogeneouslik
pcr
amplif
environ
condit
reduc
primerdim
format
nonspecif
primer
hybrid
amplif
bia
ie
major
caus
pcr
ineffici
earli
amplif
cycl
allow
increas
product
yield
due
close
proxim
micel
templat
dna
primer
polymeras
high
local
concentr
histor
enrich
aptam
pool
selex
experi
clone
plasmid
hundr
individu
clone
sequenc
identifi
high
affin
aptam
howev
recent
applic
nextgener
sequenc
ng
combin
bioinformat
analysi
grow
aptam
popul
power
improv
selex
procedur
analysi
evolv
aptam
popul
selex
mani
sequenc
famili
obtain
approach
proper
algorithm
search
structur
motif
might
critic
aptamertarget
interact
next
step
obtain
function
aptam
structureand
sequenceguid
molecular
engin
includ
truncat
andor
mutat
sequenc
develop
shortest
aptam
highest
affin
specif
identifi
put
aptam
synthes
analyz
determin
target
affin
specif
bind
vs
possibl
target
structur
character
import
optim
aptam
featur
select
pool
comput
analysi
predict
nucleotid
base
import
ligand
bind
biophys
studi
nmr
xray
crystallographi
identifi
molecular
detail
aptamertarget
interact
biophys
analys
far
definit
inform
techniqu
resolv
tertiari
structur
howev
limit
buffer
condit
compat
data
collect
interact
site
aptam
target
establish
biochem
assay
nucleas
protect
uvcrosslink
assay
perform
select
presenc
absenc
target
inform
bind
pocket
base
critic
target
contact
essenti
aptam
optim
provid
map
guid
insert
modif
retain
increas
bind
affin
alter
aptam
properti
size
structur
stabil
anoth
import
consider
aptam
develop
target
use
select
process
ident
natur
one
ie
case
protein
target
exampl
similar
protein
found
vivo
requir
frequent
fulfil
use
selex
target
protein
might
modifi
short
tag
often
difficult
ensur
ident
natur
target
membran
protein
small
molecul
modifi
allow
immobil
selex
captur
protocol
inde
isol
membran
protein
use
selex
may
lack
normal
glycosyl
pattern
associ
natur
partner
protein
lipid
carbohydr
influencemodul
structur
avail
surfac
dock
site
affin
aptam
prevent
access
natur
target
address
problem
select
techniqu
like
cellselex
tissueselex
develop
method
provid
effect
approach
identif
new
biomark
diseas
signal
diagnosi
therapi
howev
cellselex
system
provid
low
aptam
enrich
effici
mani
offtarget
surfac
biomark
coexpress
cell
interest
overcom
challeng
modifi
selex
method
combin
cellbas
selex
purifi
proteinbas
selex
techniqu
introduc
hybrid
selex
addit
hybridselex
approach
modifi
cellselex
technolog
develop
intern
cellselex
design
select
function
aptam
intern
human
cell
facsselex
use
elimin
dead
cell
nonspecif
bind
nucleic
acid
affect
subsequ
aptam
select
result
despit
advanc
huge
bodi
literatur
document
success
aptam
commerci
applic
remain
rel
undevelop
probabl
overwhelm
antibodybas
market
certain
degre
hesit
move
new
type
product
howev
mani
advanc
made
improv
effici
select
increas
affin
specif
bioavail
aptam
futur
therapeut
aptam
look
extrem
promis
date
macugen
pegaptanib
sodium
select
vascular
endotheli
growth
factor
vegf
exist
aptamerbas
drug
approv
us
food
drug
administr
treatment
neovascular
agerel
macular
degener
amd
human
also
undergo
clinic
trial
treatment
diabet
macular
oedema
nevertheless
new
aptamerbas
candid
adapt
ref
permiss
royal
societi
chemistri
drug
undertak
clinic
trial
give
us
hope
increasingli
aptam
aptamerlik
compound
approv
drug
next
futur
among
combinatori
select
aptam
endow
signific
bioactiv
mani
grich
oligom
share
common
structur
featur
ie
abil
fold
stabl
gquadruplex
conform
physiolog
condit
recogn
differ
protein
target
appar
contrast
easili
solv
consid
extrem
high
polymorph
gquadruplex
structur
fact
gquadruplex
noncanon
nucleic
acid
conform
adopt
guaninerich
oligonucleotid
core
gquadruplex
unit
guanin
tetrad
cyclic
planar
arrang
four
guanin
link
hoogsteentyp
hydrogen
bond
stack
two
guanin
tetrad
gener
gquadruplex
motif
stabil
cation
host
central
caviti
fig
discoveri
aptam
demonstr
unusu
dna
structur
even
similar
sequenc
result
larg
varieti
differ
conform
thu
embodi
suffici
element
recognit
wide
rang
unrel
protein
system
account
divers
biolog
effect
produc
appar
rigid
structur
instead
rather
plastic
fit
wide
differ
nucleic
acid
architectur
multipl
element
particip
confer
structur
high
level
adapt
intramolecular
intermolecular
charact
system
parallel
antiparallel
direct
guaninerich
tract
assembl
length
sequenc
direct
loop
syn
anti
guanin
orient
around
nglycosid
bond
number
consecut
gquartet
form
bodi
evid
thu
far
gain
indic
intramolecular
conform
gener
favour
loop
consist
base
often
adopt
antiparallel
arrang
altern
synanti
orient
prefer
number
consecut
gquartet
avoid
excess
conform
stiff
furthermor
individu
differenti
element
addit
present
aptam
bulg
mix
g
g
g
g
g
c
g
c
tetrad
gvacanc
atetrad
sandwich
gtetrad
pentad
addit
level
structur
divers
relat
possibl
rais
dna
rna
aptam
one
possibl
explan
high
number
sequenc
found
aptam
select
process
signific
charg
densiti
gquadruplex
dnatwic
neg
charg
per
unit
length
compar
duplex
dna
consequ
high
electrostat
potenti
provid
strong
bind
posit
charg
surfac
protein
although
hydrophob
interact
also
critic
strong
specif
bind
target
last
two
decad
aptam
prove
attract
therapeut
agent
mainli
enhanc
cellular
uptak
nonimmunogen
lower
product
cost
sever
aptam
differ
human
patholog
neurodegen
diseas
agerel
macular
degener
inflamm
thrombosi
diabet
etc
discov
evalu
abil
aptam
recogn
variou
protein
play
fundament
role
differ
patholog
open
way
develop
dna
rna
therapeut
agent
focu
particular
aptam
popular
prove
potenti
drug
cancer
human
immunodefici
viru
hiv
coagul
tabl
anticanc
discov
coincid
convent
selex
approach
advanc
cancer
therapeut
formal
name
advanc
firstinclass
anticanc
aptam
enter
clinic
trial
dna
aptam
highli
stabl
resist
nucleas
degrad
target
nucleolin
nucleolin
ubiquit
multifunct
protein
play
essenti
role
cell
surviv
growth
prolifer
bind
extern
domain
nucleolin
overexpress
surfac
cancer
cell
therefor
abl
specif
recogn
taken
cancer
cell
intern
aptamernucleolin
complex
inhibit
dna
replic
result
accumul
cell
phase
cytotox
cancer
cell
recent
novel
mechan
action
propos
intern
via
nucleolinmedi
macropinocytosi
intern
aptamernucleolin
complex
hyperstimul
macropinocytosi
caus
nonapoptot
cell
death
known
methuosi
preclin
studi
shown
antiprolif
activ
sever
cell
line
includ
lung
prostat
breast
cancer
cell
activ
also
prove
nude
mice
result
signific
growth
reduct
xenograft
model
prostat
cancer
phase
clinic
trial
well
toler
patient
advanc
solid
tumor
without
seriou
toxic
phase
ii
clinic
trial
shown
promis
activ
metastat
renal
cell
carcinoma
acut
myeloid
leukemia
minim
toxic
protein
signal
transduc
activ
transcript
involv
cellular
differenti
prolifer
apoptosi
overactiv
mani
type
human
cancer
oligonucleotid
form
stabl
gquadruplex
target
dimer
inhibit
dna
bind
activ
inject
caus
signific
reduct
express
increas
apoptosi
process
suppress
growth
prostat
breast
xenograft
tumor
nude
mice
protein
famili
tyrosin
phosphatas
involv
numer
essenti
cellular
process
cell
growth
tabl
stateoftheart
known
aptam
aptam
vitro
studi
ic
differenti
oncogen
transform
thu
consid
key
target
differ
human
diseas
mainli
cancer
patholog
selex
method
allow
identifi
dna
aptam
select
recogn
bind
phosphatas
affin
nanomolar
rang
strongli
inhibit
activ
ic
nm
adopt
structur
prerequisit
stabl
bind
vegf
protein
act
key
regul
angiogenesi
thu
play
import
role
sever
diseas
agerel
macular
degener
cancer
vegf
differ
isoform
preval
identifi
aptam
vegf
three
round
selex
sequenc
tgtgggggtggacg
ggccgggtaga
fold
stabl
gquadruplex
structur
basi
truncat
mutant
design
guanin
tract
necessari
form
gquartet
conserv
fold
sever
structur
strongli
bind
low
nanomolar
k
valu
use
silico
matur
increas
aptam
bind
affin
class
mutant
design
studi
best
aptam
select
higher
affin
target
k
pm
mani
grich
sequenc
identifi
aptam
activ
infect
agent
hepat
c
viru
hcv
sever
acut
respiratori
syndrom
coronaviru
sarscov
class
antivir
aptam
far
repres
certainli
hiv
inde
among
antihiv
agent
mani
aptam
abl
interact
hiv
envelop
glycoprotein
bind
cellular
receptor
favour
viru
entri
b
hiv
integras
c
hiv
revers
transcriptas
inhibit
respect
viru
bind
entri
target
cell
viral
genom
integr
revers
transcript
detail
overview
antihiv
agent
base
gquadruplex
form
oligonucleotid
develop
last
two
decad
recent
report
research
group
viru
attach
inhibitor
upon
screen
librari
phosphorothio
octanucleotid
contain
possibl
sequenc
first
antihiv
identifi
ttggggtt
isi
form
tetramolecular
parallel
gquadruplex
inhibit
hiv
infect
submicromolar
concentr
ic
due
highli
anion
charact
strongli
interact
cation
loop
envelop
glycoprotein
inhibit
viru
adsorpt
cell
fusion
seri
hexadeoxyribonucleotid
carri
variou
modif
either
end
base
call
tgggag
hotoda
sequenc
also
synthes
evalu
vitro
antihiv
activ
prove
potent
inhibitor
ic
valu
submicromolar
nanomolar
concentr
besid
main
cellular
receptor
hiv
entri
two
chemokin
receptor
viru
attach
also
occur
interact
heparan
sulfat
proteoglycan
nucleolin
host
cellsurfac
therefor
also
target
nucleolin
interfer
hiv
attach
demonstr
use
show
mark
antivir
activ
vitro
test
shown
effect
hiv
low
nanomolar
concentr
ec
nm
thu
prove
potent
antivir
anticanc
agent
viru
integr
inhibitor
antihiv
integras
activ
found
aptam
sequenc
ggggtgggagg
agggt
adopt
peculiar
dimer
interlock
structur
exhibit
vitro
inhibitori
activ
nanomolar
rang
remark
inhibit
hiv
integras
ic
valu
nanomolar
rang
observ
also
aptam
sequenc
gtggtgggtgggtgggt
contain
singl
phosphorothio
internucleosid
linkag
oligonucleotid
show
unusu
high
nucleas
resist
physiolog
environ
due
capac
form
stabl
dimer
structur
involv
two
subunit
propellertyp
parallelstrand
gquadruplex
first
hiv
integras
inhibitor
test
clinic
trial
zintevir
aronex
pharmaceut
revers
transcript
inhibitor
hiv
revers
transcriptas
rt
multifunct
enzym
compos
two
domain
dna
polymeras
domain
convert
viral
rna
genom
dna
cytoplasm
host
cell
rnase
h
domain
specif
cleav
rna
strand
rnadna
heteroduplex
first
hiv
rt
inhibitor
identifi
aptam
bimodular
structur
compris
modul
connect
modul
dna
aptam
rnase
h
domain
rt
identifi
selex
procedur
use
recombin
rt
without
rnase
h
domain
two
aptam
odn
select
inhibit
hiv
rnase
h
ic
valu
submicromolar
rang
show
activ
human
enzym
thrombin
serin
proteas
play
key
role
last
step
blood
clot
process
convert
solubl
fibrinogen
insolubl
fibrin
first
anticoagul
aptam
target
thrombin
describ
bock
et
al
subsequ
dna
aptam
also
discov
thrombin
inhibitor
adopt
gquadruplex
structur
tba
thrombinbind
aptam
tba
also
known
archemix
nuvelo
dna
aptam
target
thrombin
exosit
nanomolar
affin
rang
nm
fold
chairlik
gquadruplex
structur
consist
two
gquartet
tgt
loop
two
tt
loop
phase
clinic
trial
tba
test
put
anticoagul
coronari
arteri
bypass
graft
surgeri
preliminari
result
confirm
desir
doserel
anticoagul
activ
howev
high
amount
need
obtain
desir
anticoagul
effect
result
suboptim
dose
profil
therefor
archemix
nuvelo
interrupt
phase
clinic
trial
tba
claim
focu
improv
second
gener
aptam
dna
aptam
duplexgquadruplex
mix
structur
recogn
heparinbind
exosit
ii
thrombin
inhibit
thrombinmedi
activ
platelet
bind
constant
nanomolar
rang
show
higher
affin
thrombin
tba
bival
dna
aptam
consist
exosit
bind
aptam
tba
exosit
ii
bind
aptam
connect
polyda
linker
bind
thrombin
higher
affin
precursor
aptam
alon
abl
prolong
thrombin
clot
time
dosedepend
manner
prove
strong
inhibitor
thrombin
activ
bival
dna
aptam
consist
two
coval
bound
gquadruplex
contain
tba
motif
connect
via
thymin
linker
bind
thrombin
exosit
block
fibrinogen
bind
enzym
dosedepend
effect
thu
result
effici
thrombin
inhibitor
anim
test
shown
aptam
show
high
speciesspecif
discov
selex
subsequ
truncat
nucleotid
arca
biopharma
dna
aptam
target
thrombin
exosit
abl
fold
structur
preclin
studi
shown
abil
prolong
thrombin
clot
time
furthermor
due
rapid
nucleas
degrad
anticoagul
activ
halt
without
use
antidot
phase
ii
clinic
trial
test
anticoagul
efficaci
coronari
arteri
bypass
graft
surgeri
unknown
statu
skelet
diseas
sclerostin
extracellular
protein
involv
neg
regul
bone
growth
reason
key
target
treatment
osteoporosi
parallel
aptam
identifi
evalu
sclerostin
vitro
studi
shown
aptam
specif
bind
sclerostin
affin
nanomolar
rang
prion
diseas
prion
diseas
neurodegen
disord
mammal
due
convers
solubl
normal
cellular
prion
protein
prp
c
insolubl
abnorm
isoform
prp
sc
accumul
brain
target
prp
c
strategi
stabil
normal
prion
protein
avoid
convers
abnorm
prp
sc
form
mashima
et
al
discov
rna
aptam
bovin
prp
c
sequenc
r
ggaggaggagga
fold
dimer
gquadruplex
structur
exhibit
antiprion
activ
mous
result
prp
sc
level
reduct
tuberculosi
inorgan
polyphosph
act
key
regul
mycobacteri
stress
virul
polyphosph
kinas
ppk
major
enzym
involv
polyphosph
metabol
prove
key
target
mycobacterium
tuberculosi
shum
et
al
identifi
non
aptam
one
two
class
tuberculosi
ppk
aptam
prove
effect
bind
protein
inhibit
catalyt
activ
ic
nm
mutat
analysi
provid
evid
key
role
play
gquadruplex
architectur
specif
strong
bind
take
account
known
anticancerantivir
drug
candid
drug
associ
heavi
side
effect
due
intrins
poor
select
effici
target
drugdeliveri
system
urgent
requir
due
abil
strongli
select
recogn
protein
target
aptam
help
also
specif
target
inde
aptam
conjug
drug
choic
order
deliv
toward
specif
receptor
usual
cell
surfac
protein
overexpress
target
cell
underexpress
nontarget
healthi
cell
interest
case
abovediscuss
aptam
act
potenti
drug
promis
antitumor
antihiv
activ
drugdeliveri
system
effici
select
intern
nucleolin
overexpress
cancer
cell
macropinocytosi
particular
sever
research
group
focus
attent
drugdeliveri
approach
develop
essenti
three
differ
kind
system
conjug
system
valuabl
exampl
report
shieh
et
al
describ
conjug
use
photodynam
therapi
hypothes
mechan
action
follow
complex
effici
taken
cell
exploit
bind
nucleolin
light
exposur
activ
destroy
cell
carri
intern
complex
vitro
studi
shown
conjug
preferenti
accumul
breast
cancer
cell
epithelium
normal
cell
furthermor
photodamag
produc
conjug
overal
extens
cancer
cell
normal
cell
result
prove
deliveri
uptak
effect
mediat
specif
interact
complex
nucleolin
le
trinh
et
al
crosslink
doxorubicin
known
chemotherapeut
agent
vivo
test
murin
xenograft
model
shown
inject
adduct
result
reduc
antitumor
activ
compar
free
doxorubicin
also
signific
reduct
typic
side
effect
associ
doxorubicin
treatment
cardiotox
nephrotox
weight
loss
anoth
adduct
develop
liu
et
al
construct
dimer
nanocarri
consist
domain
respons
select
target
cancer
cell
dna
duplex
domain
necessari
captur
transport
doxorubicin
nanosystem
show
effici
vitro
vivo
antitumor
activ
drugresist
breast
cancer
cell
reduc
toxic
compar
free
doxorubicin
order
select
deliv
higher
amount
chemotherapeut
cancer
cell
liao
et
al
propos
use
doxorubicincontain
liposom
function
thiolderivat
first
conjug
maleimidepeg
via
format
thioether
linkag
purifi
conjug
selfassembl
spheric
micel
incub
liposom
allow
micel
compon
exchang
liposom
bilay
vivo
studi
nude
mice
shown
deliv
liposom
doxorubicin
preferenti
accumul
tumour
tissu
respect
free
doxorubicin
inhibit
tumour
growth
minim
toxic
compar
free
drug
final
guo
et
al
develop
nanoparticl
deliv
paclitaxel
potent
chemotherapeut
agent
vivo
studi
nanoparticl
shown
enhanc
paclitaxel
accumul
tumor
cell
higher
reduct
glioma
weight
nude
mice
compar
free
paclitaxel
anoth
aptam
potenti
use
drug
deliveri
name
discov
meyer
et
al
rna
aptam
sequenc
r
ggggaggcuguggugaggg
specif
recogn
receptor
cytokin
play
key
role
inflammatori
diseas
cancer
prove
specif
deliv
protein
toward
cell
express
receptor
surfac
hepatocyt
monocyt
macrophag
lymphocyt
hivinfect
cell
stimul
research
novel
drug
deliveri
system
use
anticanc
also
antihiv
treatment
overal
analysi
known
therapeut
aptam
provid
interest
pictur
gener
conclus
drawn
first
signific
number
aptam
select
cancer
cell
adopt
structur
preferenti
conform
presenc
fold
appear
essenti
structur
motif
aptam
endow
cancerselect
antiprolif
activ
upon
screen
oligonucleotid
combinatori
librari
differ
nucleobas
composit
length
bate
et
al
found
grich
librari
show
featur
consist
format
strongli
inhibit
cancer
cell
growth
contrast
affect
healthi
cell
parallel
topolog
seem
larg
prevail
among
bioactiv
aptam
one
remark
exampl
nucleolinbind
aptam
advanc
phase
ii
clinic
trial
renal
cell
carcinoma
even
present
mixtur
differ
monomer
even
dimer
conform
essenti
prefer
parallel
structur
anoth
studi
investig
antiprolif
effect
aptam
shangguan
et
al
suggest
intramolecular
parallel
structur
may
key
featur
cellular
protein
recognit
allow
effici
cell
uptak
endosomelysosom
pathway
studi
carri
number
parallel
structur
includ
put
sequenc
human
genom
find
support
idea
structureact
relationship
analys
speed
identif
scaffold
use
design
optim
therapeut
activ
aptam
thu
aptam
select
perform
use
partial
random
grich
oligonucleotid
librari
combin
selex
ration
design
method
howev
case
even
minor
mutat
sequenc
may
dramat
effect
aptam
stabil
andor
activ
induc
mark
alter
topolog
eg
intramolecular
antiparallel
convert
intermolecular
parallel
one
caus
aptam
target
differ
epitop
protein
thu
random
process
alway
compromis
need
highest
sequenc
permut
stabl
case
intermolecular
scaffold
combinatori
librari
usual
contain
sever
consecut
guanin
grun
random
flank
case
intramolecular
scaffold
core
typic
kept
intact
loop
random
promis
strategi
increas
molecular
divers
aptam
within
combinatori
drug
discoveri
approach
exploit
modular
assembl
activ
modul
link
duplex
motif
get
hybrid
structur
improv
thermodynam
stabil
altern
polyval
aptam
obtain
conjug
similar
differ
modul
homopolyval
heteropolyval
aptam
respect
abl
recogn
distinct
site
target
protein
differ
target
synergist
effect
link
domain
typic
expect
polyval
system
case
howev
success
overal
strategi
critic
depend
choic
linker
modul
context
combinatori
librari
random
linker
fix
activ
modul
fruit
use
anoth
central
issu
due
abund
motif
human
genom
play
divers
regulatori
role
varieti
genom
motif
particularli
locat
gene
promot
regard
potenti
candid
aptam
word
aptam
design
take
inspir
natur
nucleic
acid
substrat
use
competitor
endogen
regulatori
protein
ultim
affect
gene
express
normal
cell
function
regard
valuabl
exampl
oligonucleotid
carri
sequenc
locat
insulin
promot
found
recogn
insulin
insulinlik
growth
factor
promoterderiv
aptam
select
method
success
use
identifi
good
affin
vegf
plateletderiv
growth
factoraa
retinoblastoma
protein
nativ
modifi
mimic
ra
protooncogen
abl
compet
dnaprotein
complex
regul
transcript
therefor
use
decoy
transcript
factor
ration
design
decoy
first
describ
xodo
et
al
appear
promis
strategi
anticanc
research
parallel
expect
new
effect
antivir
agent
develop
consequ
rapid
progress
studi
sequenc
epsteinbarr
viru
papilloma
viru
genom
particip
viral
life
cycl
hope
geneinspir
aptam
discov
near
futur
consid
advantag
discuss
wide
target
librari
high
affin
stabil
select
capabl
form
specif
watsoncrick
andor
hoogsteen
hbond
surpris
nucleic
acid
aptam
emerg
key
recognit
element
also
design
novel
biosensor
ie
call
aptasensor
combin
variou
sens
strategi
compat
almost
kind
target
detect
requir
readout
techniqu
sens
process
aptasensor
similar
biosensor
aptam
recogn
target
signal
transduc
transfer
recognit
inform
measur
signal
aptam
immobil
heterogen
use
solut
homogen
phase
immobil
aptam
abl
releas
target
upon
wash
differ
buffer
thu
allow
principl
reus
aptasensor
sever
time
multipl
sens
strategi
develop
till
combin
variou
transduc
quartz
crystal
microbal
qcm
surfac
plasmon
reson
spr
fluoresc
colorimetri
electrophoresi
electrochemistri
electrochemiluminesc
ecl
fieldeffect
transistor
aptasensor
gener
divid
two
class
label
labelfre
sensor
recent
develop
use
aptam
diagnost
imag
recent
review
neerathilingam
et
al
discuss
detail
applic
aptam
detect
infect
agent
antigen
toxin
bacteria
biomark
cancer
specif
case
aptam
versatil
plastic
structur
fruit
exploit
variou
type
detect
assay
studi
aptam
mani
diagnost
applic
thrombin
bind
aptam
tba
two
short
dna
sequenc
tba
tba
nucleotid
length
rel
easi
inexpens
synthes
abl
recogn
high
affin
specif
fibrinogenand
heparinrecognit
exosit
thrombin
respect
exosit
ii
despit
high
biolog
signific
thrombin
target
tba
tba
properli
modifi
fulfil
desir
detect
process
wide
use
essenti
proofofconcept
verifi
feasibl
propos
analyt
method
success
tba
model
system
develop
detect
assay
due
sever
factor
high
affin
specif
target
avail
two
thrombin
aptam
target
specif
exosit
protein
noninterf
manner
give
possibl
perform
sandwichtyp
assay
rapid
unambigu
switch
aptam
structur
trigger
thrombin
bind
catalyt
activ
protein
still
present
bind
event
aptam
scientif
literatur
plenti
research
studi
detect
thrombin
base
either
complic
multirecognit
system
rapid
easi
method
group
homogenousor
heterogeneousphas
assay
use
label
labelfre
well
enzymeassist
assay
detail
recent
review
illustr
develop
one
hundr
analyt
techniqu
center
tbathrombin
system
see
also
ref
report
updat
recent
tbabas
sens
system
discuss
parallel
less
recent
assay
select
basi
appar
effici
simplic
yan
et
al
develop
probe
thrombin
sens
base
tba
multibranch
fluoresc
pyrazin
deriv
taspi
upon
strongli
interact
singl
strand
dna
turn
bright
fluoresc
presenc
thrombin
specif
bind
tba
induc
fold
antiparallel
gquadruplex
structur
taspi
molecul
releas
aptam
result
vivid
facil
fluoresc
recoveri
turn
system
fig
interestingli
approach
employ
also
real
plasma
sampl
coagul
process
anoth
similar
exampl
detect
thrombin
report
facil
sensit
labelfre
homogen
assay
approach
zhang
et
al
use
cdte
quantum
dot
qd
cd
ion
tba
qd
activ
fluoresc
enhanc
ad
extra
cd
solut
basic
medium
posit
charg
cd
activ
cdte
qd
interact
neg
charg
tba
lead
fluoresc
quench
thrombin
ad
tba
form
gquadruplex
structur
specif
interact
target
releas
qd
recoveri
fluoresc
intens
fig
linear
respons
thrombin
observ
rang
nm
nm
detect
limit
nm
method
easi
perform
sinc
coval
modif
immobil
aptam
avoid
reduc
background
signal
improv
sensit
due
turnon
sens
mode
perform
directli
real
serum
sampl
requir
pretreat
serum
matrix
remark
fluoresc
enhanc
upon
thrombin
recognit
obtain
also
use
dansylcyclodextrintag
tba
case
thrombin
bind
tba
produc
fluoresc
enhanc
due
encapsul
dansyl
attach
tba
apolar
caviti
aptam
sequenc
similarli
anoth
aptamerbas
turnon
thrombin
biosensor
base
mndope
zn
quantum
dot
whose
phosphoresc
restor
thrombinaptam
recognit
system
involv
effici
phosphoresc
energi
transfer
pet
donoracceptor
pair
mndope
zn
quantum
dot
label
thrombinbind
aptam
tba
qd
donor
carbon
nanodot
cnd
acceptor
due
stack
interact
aptam
cnd
energi
donor
acceptor
taken
close
proxim
lead
phosphoresc
quench
tba
qddonor
introduct
thrombin
onto
tbaqdscnd
system
state
phosphoresc
turn
due
format
complex
releas
energi
acceptor
cnd
energi
donor
fig
sensor
display
linear
rang
nm
thrombin
detect
limit
nm
pure
buffer
propos
aptasensor
also
use
monitor
thrombin
complex
biolog
fluid
includ
serum
plasma
satisfactori
recoveri
rang
result
explain
interfer
phosphoresc
deriv
autofluoresc
scatter
light
complex
matrix
easili
avoid
also
chemiluminesc
employ
turnoff
solut
assay
thrombin
detect
case
tba
conjug
react
tmpg
presenc
tetranpropylammonium
hydroxid
tpa
highenergi
intermedi
form
transfer
energi
emit
bright
light
base
chemiluminesc
energi
transfer
cret
presenc
thrombin
bright
guanin
chemiluminesc
quench
due
format
gquadruplex
tbaconjug
bound
target
fig
detect
limit
aptasensor
good
linear
calibr
curv
accuraci
precis
recoveri
nm
human
serum
anoth
studi
colorimetr
ultrasensit
thrombindetect
assay
employ
elong
variant
tba
cation
polym
poli
diallyldimethylammonium
chlorid
pdda
gold
nanoparticl
sens
element
initi
cation
polym
interact
tba
dispers
gold
nanoparticl
confer
winer
color
solut
upon
thrombin
addit
target
strongli
interact
tba
probe
displac
cation
polym
turn
induc
gold
nanoparticl
aunp
aggreg
event
produc
visibl
chang
color
redwin
bluepurpl
detect
also
nake
eye
fig
colorimetr
sensor
could
detect
thrombin
pm
high
select
also
presenc
interf
protein
success
appli
determin
thrombin
level
human
serum
sampl
complic
ultrasensit
assembl
system
thrombin
detect
base
offonoff
electrochemiluminesc
ecl
approach
system
compos
eu
dope
cd
nanocryst
cd
eu
nc
film
glassi
carbon
electrod
gce
ecl
emitt
aunp
label
hairpindna
probe
fig
contain
tba
link
nc
film
ecl
quench
effect
produc
result
energi
transfer
fret
cd
eu
nc
film
proxim
aunp
upon
hybrid
free
ssdna
complementari
hairpin
duplex
structur
form
aunp
pull
away
cd
eu
nc
film
caus
ecl
enhanc
due
interact
excit
cd
eu
nc
eclinduc
surfac
plasmon
reson
spr
aunp
larg
separ
addit
thrombin
induc
form
gquadruplex
structur
displac
allow
aunp
get
close
cd
eu
nc
film
eventu
produc
enhanc
ecl
quench
offonoff
system
show
maximum
chang
ecl
intens
due
configur
transform
provid
great
sensit
thrombin
detect
wide
detect
rang
pm
recent
novel
labelfre
electrochem
aptasens
platform
rapid
facil
detect
thrombin
use
graphen
oxid
go
modifi
pencil
graphit
electrod
tba
design
strategi
reli
preferenti
adsorpt
singlestrand
dna
ssdna
go
aptamertarget
complex
tbathrombin
complex
format
monitor
differenti
puls
voltammetri
dpv
use
guanin
oxid
signal
absenc
thrombin
aptam
adsorb
onto
surfac
go
lead
strong
background
guanin
oxid
signal
convers
presenc
thrombin
conform
transform
tba
incub
thrombin
solut
format
aptamerthrombin
complex
weak
bind
affin
go
lead
desorpt
tbathrombin
complex
electrod
surfac
signific
oxid
signal
decreas
fig
select
biosensor
studi
use
biolog
substanc
biosensor
signal
proport
thrombin
concentr
nm
detect
limit
nm
order
evalu
analyt
reliabl
applic
potenti
biosensor
clinic
analysi
propos
biosensor
use
detect
thrombin
healthi
human
blood
serum
sampl
optim
experiment
condit
similar
respons
found
buffer
serum
sampl
prove
applic
propos
sensor
real
sampl
analysi
moreov
biosensor
use
determin
thrombin
concentr
spike
dilut
serum
sampl
standard
addit
method
obtain
result
measur
four
differ
concentr
show
good
recoveri
valu
indic
propos
biosensor
high
accuraci
practic
applic
use
thrombin
detect
real
biolog
sampl
mani
sens
system
detect
thrombin
protein
target
therapeut
relev
requir
enzymat
activ
obtain
signal
transduct
produc
fluoresc
colorimetr
electrochem
chang
import
advanc
field
aptasensor
came
discoveri
peroxidas
activ
associ
complex
dnazym
initi
specif
aptam
bind
iron
iii
protoporphyrin
ix
hemin
select
grich
dna
sequenc
abl
form
stabl
gquadruplex
structur
demonstr
aptamerhemin
complex
significantli
higher
peroxidas
activ
hemin
alon
physiolog
condit
catalyz
dnazym
oxid
acid
abt
hydrogen
peroxid
h
concomit
format
color
radic
cation
product
peroxidas
activ
also
significantli
higher
previous
report
hemincatalyticantibodi
complex
later
realiz
rna
version
also
show
enhanc
peroxidas
activ
demonstr
rnabas
aptam
similar
structur
function
intramolecular
gquadruplex
structur
shown
play
import
role
peroxidas
activ
gener
dna
ligand
porphyrin
ring
hemin
bind
also
gquadruplex
famili
point
inde
investig
explor
interact
hemin
gquadruplex
aptam
discov
aptam
abl
bind
hemin
differ
affin
depend
type
structur
peroxidas
activ
dnazym
regard
sens
system
addit
abt
mani
compound
also
act
substrat
oxid
h
upon
complex
catalysi
luminol
produc
chemiluminesc
chemiluminesc
reson
energi
transfer
dab
etc
peroxidasemimick
activ
dnazym
relat
topolog
conform
structur
remark
parallel
gquadruplex
display
much
higher
peroxidas
activ
display
hemin
antiparallel
gquadruplex
also
tba
bind
hemin
occur
aptam
fold
state
thu
form
stabl
complex
weak
peroxidaselik
activ
incub
thrombin
tbahemin
complex
recogn
protein
target
form
supramolecular
dnazym
significantli
increas
catalyt
activ
recognit
event
produc
absorb
chang
abtsh
system
easili
monitor
use
uvvi
absorpt
spectroscopi
fig
thu
provid
facil
approach
reveal
thrombin
detect
limit
nm
improv
sensit
respect
colorimetr
assay
abt
obtain
combin
tba
gquadruplexbas
dnazym
tbaheminthrombin
h
thiamin
fluoresc
system
h
mediat
oxid
thiamin
cheap
fluoresc
substrat
give
rise
fluoresc
emiss
fig
allow
quantit
analysi
thrombin
detect
limit
pm
employ
synergist
effect
hemingquadruplex
peroxidas
activ
enzymat
activ
alkalin
phosphatas
alp
well
sandwichtyp
recognit
thrombin
two
tba
tba
tba
specif
exosit
ii
target
protein
respect
ingeniouslydesign
sensit
electrochem
aptasensor
thrombin
obtain
thrombin
aptasensor
compos
two
system
goldnanoparticledecor
zinc
oxid
nanoflow
auzno
matrix
immobil
alp
tba
label
hemin
form
hemingquadruplexalpauzno
bioconjug
solid
platform
sens
interfac
constitut
gce
thin
layer
aunp
function
tba
deposit
thrombin
detect
obtain
exploit
sandwichtyp
recognit
led
close
proxim
tba
auzno
bioconjug
tba
aunp
modifi
electrod
condit
upon
addit
phosphat
alp
effici
catalyz
oxid
surfac
electrod
hand
could
oxid
hemintbathrombin
system
presenc
h
result
final
promot
electron
transfer
electrod
amplif
electrochem
signal
enzymeassist
signal
amplif
strategi
incorpor
assay
increas
sensit
electrochem
aptasensor
fig
propos
thrombin
aptasensor
yield
linear
respons
rang
nm
detect
limit
pm
similar
system
author
use
anoth
enzym
glucos
oxidas
gox
construct
sensit
electrochem
aptasensor
thrombin
exploit
enzymeassist
signal
amplif
strategi
employ
synergist
effect
hemin
peroxidas
mimic
enzymat
activ
gox
sandwichtyp
recognit
thrombin
two
tba
tba
tba
system
obtain
combin
two
compon
multifunct
bionanocomposit
solut
compos
nanos
mof
encapsul
hemin
function
gold
nanoparticl
glucos
oxidas
tba
fig
solid
platform
sens
interfac
constitut
gce
thin
layer
aunp
function
tba
deposit
fig
sandwichtyp
recognit
involv
auhemin
moftba
gox
bioconjug
tba
aunp
modifi
electrod
allow
sensit
thrombin
detect
fig
upon
addit
glucos
gox
effici
catalyz
oxid
glucos
gluconolacton
coupl
local
format
h
presenc
dissolv
gener
h
electrod
surfac
reduc
hemin
mof
system
final
promot
electron
transfer
electrod
signal
amplif
thu
enzymeassist
signal
amplif
strategi
increas
sensit
construct
electrochem
aptasensor
employ
hemin
adapt
permiss
ref
copyright
american
chemic
societi
adapt
permiss
ref
copyright
royal
societi
chemistri
mof
redox
mediat
signal
gener
base
revers
redox
fe
iii
fe
ii
within
hemin
soobtain
sandwichtyp
aptasensor
show
good
sensit
stabil
satisfactori
reproduc
well
good
precis
thrombin
determin
serum
indic
method
potenti
use
detect
protein
complex
sampl
anoth
detect
method
base
enzymaticallyassist
assay
catalyt
activ
target
ie
thrombin
exploit
inde
thrombin
proteas
enzym
specif
catalyz
cleavag
protein
peptid
bind
site
aptam
protein
differ
enzym
catalyt
site
absenc
aptam
bind
thrombin
enzymat
activ
thrombin
maintain
use
develop
detect
method
blood
sampl
process
anticoagul
buffer
citrat
contain
revers
activesit
inhibitor
argatroban
fig
ad
blood
sampl
contain
thrombin
pdb
complex
format
argatroban
thrombin
effici
prevent
irrevers
inhibit
thrombin
endogen
thrombin
inhibitor
well
streptavidinco
microtit
modul
previous
load
antithrombin
aptam
simultan
target
exosit
ii
thrombin
overlaid
plasma
incub
captur
argatrobanthrombin
complex
well
wash
remov
plasma
remain
revers
bound
argatroban
subsequ
thrombinspecif
peptid
substrat
bear
amc
fluorogen
probe
hdchaalaargamc
ad
quantit
determin
amount
function
activ
thrombin
captur
well
thu
supramolecular
oligonucleotidebas
enzym
captur
assay
sensit
detect
thrombin
develop
plasma
routin
clinic
condit
addit
thrombin
two
wellknown
aptam
name
zintevir
analogu
identifi
discuss
highaffin
binder
protein
nucleolin
integras
respect
effect
anticanc
antihiv
biolog
activ
exhibit
high
heminbind
affin
compar
known
aptam
term
select
vitro
evolut
process
capabl
simultan
bind
protein
target
hemin
two
differ
mode
importantli
correspond
hemindna
complex
reveal
excel
peroxidaselik
activ
higher
report
dnazym
potenti
system
bioanalysi
demonstr
appli
chemiluminesc
detect
nucleolin
express
surfac
hela
cell
base
specif
interact
surfaceexpress
nucleolin
hela
cell
label
situ
dnazym
determin
luminolh
system
fig
approach
sensit
detect
total
nucleolin
express
surfac
hela
cell
accomplish
anoth
aptam
probe
great
potenti
use
tool
earli
diagnosi
prognosi
cancer
identifi
selex
subsequ
optim
specif
bind
anterior
gradient
homolog
good
cancer
biomark
structur
studi
identifi
bind
motif
aptam
intramolecular
parallel
gquadruplex
structur
structur
bind
fig
gener
principl
oligonucleotidebas
enzym
captur
assay
thrombin
detect
develop
et
al
blood
sampl
process
anticoagul
buffer
citrat
contain
revers
activesit
inhibitor
argatroban
ad
blood
sampl
contain
thrombin
pdb
complex
format
argatroban
thrombin
effici
prevent
irrevers
inhibit
thrombin
endogen
thrombin
inhibitor
b
well
streptavidinco
microtit
modul
previous
load
antithrombin
aptam
simultan
target
exosit
ii
thrombin
overlaid
plasma
incub
captur
argatrobanthrombin
complex
well
wash
remov
plasma
remain
revers
bound
argatroban
subsequ
thrombinspecif
peptid
substrat
bear
amc
fluorogen
probe
hdchaalaargamc
ad
quantit
determin
amount
function
activ
thrombin
captur
well
affin
strongli
depend
natur
monoval
ion
detect
alloster
molecular
beacon
name
coupl
fluoresc
flow
cytometri
sens
system
develop
fig
singl
strand
dna
consist
streptavidin
sa
aptam
sequenc
sequenc
short
sequenc
complementari
small
tract
sa
aptam
sequenc
fluorophor
stabl
hairpin
structur
form
intramolecular
hybrid
sa
aptam
sequenc
complementari
sequenc
temporarili
disabl
probe
abil
bind
sa
bead
consequ
incub
sa
bead
probe
bind
sa
bead
bead
display
low
fluoresc
presenc
howev
sequenc
loop
amb
bind
target
sequenc
turn
disrupt
hairpin
structur
releas
sa
bind
sequenc
therebi
activ
bind
affin
probe
sa
bead
thu
probe
bind
sa
bead
strongli
fluoresc
due
fam
label
probe
target
molecul
detect
quantifi
read
fluoresc
intens
sa
bead
flow
cytomet
fig
recent
possibl
detect
bacteri
pathogen
aptam
select
protein
flumagselex
process
evalu
integr
assay
call
elona
enzymelink
oligonucleotid
assay
recognit
intact
bacteri
cell
staphylococcu
aureu
present
protein
surfac
fig
protein
target
typic
compon
cell
wall
gramposit
bacterium
also
repres
one
virul
factor
render
protein
suitabl
target
detect
even
function
aptam
base
complex
highli
variabl
structur
potenti
form
dimer
multimer
gquadruplex
assembl
fulllength
aptam
one
truncat
variant
prove
specif
bind
protein
aexpress
intact
cell
aureu
give
posit
signal
assay
elona
perform
immobil
nativ
recombin
protein
microtit
plate
follow
addit
aptam
pa
bind
subsequ
wash
unbound
aptam
fig
demonstr
pa
strongli
bind
nativ
recombin
protein
clearli
distinguish
target
function
relat
protein
like
protein
g
protein
l
recogn
remark
aptam
bind
human
serum
albumin
hsa
use
unspecif
control
protein
extravidinperoxidas
conjug
appli
well
follow
wash
step
fig
success
tmb
solut
ad
well
optic
densiti
nm
measur
similar
experi
perform
coat
well
bacteri
cell
staphylococcu
aureu
assess
bind
abil
aptam
pa
truncat
variant
protein
intact
cell
context
result
elona
assay
clearli
demonstr
specif
recognit
bind
aptam
cell
via
protein
pa
truncat
variant
pa
abl
differenti
protein
aproduc
aureu
cowan
strain
protein
adefici
strain
formaldehydefix
cell
live
e
coli
fig
multifunct
aptam
better
known
dnazymebas
platform
chemiluminesc
detect
nucleolin
express
surfac
hela
cell
bind
hemin
fold
label
cellsurfaceexpress
nucleolin
situ
provid
approach
sens
protein
marker
luminolh
system
fig
work
principl
alloster
molecular
beacon
probe
sensit
select
detect
base
fluoresc
flow
cytometri
analysi
reproduc
ref
neg
control
improv
elona
assay
term
bind
result
obtain
develop
sandwich
competit
assay
fig
c
could
avoid
immobil
target
cell
improv
assay
handl
conclus
aptam
identifi
wide
varieti
protein
target
discoveri
mani
aptam
abl
recogn
even
differ
protein
fulli
demonstr
unusu
nucleic
acid
structur
either
dnaor
rnabas
may
contain
effici
recognit
element
sever
unrel
protein
system
span
coagul
cascad
spongiform
encephalopathi
despit
overal
similar
scaffold
larg
varieti
differ
structur
arrang
avail
gquadruplex
account
remark
divers
target
recognit
event
also
ensur
high
specif
bind
affin
first
aptam
identifi
thrombin
bind
aptam
tba
form
intramolecular
antiparallel
chairlik
gquadruplex
two
plane
guanin
tetrad
abl
inhibit
thrombincatalyz
polymer
fibrinogen
although
tbain
unmodifi
versiondid
prove
clinic
accept
anticoagul
still
extens
use
model
gquadruplex
structur
fundament
methodolog
proofofconcept
work
sinc
origin
studi
gquadruplex
structur
observ
main
conform
featur
varieti
aptam
select
experi
clear
evid
structur
motif
among
inform
plastic
singlestrand
nucleic
acid
structur
identifi
vitro
select
signific
number
select
cancer
cellbind
aptam
adopt
parallel
topolog
due
high
polymorph
structur
one
side
rel
pauciti
structur
studi
biolog
relev
grich
oligonucleotid
side
clear
structureact
relationship
drawn
correl
given
conform
specif
bioactiv
howev
advanc
knowledg
structur
featur
biolog
relev
oligonucleotid
allow
identifi
scaffold
essenti
design
optim
specif
therapeut
aptam
purpos
integr
approach
novel
aptam
design
combin
combinatori
method
ie
selex
variou
ration
design
method
includ
modular
assembl
approach
highli
desir
noteworthi
due
motif
abund
human
genom
divers
regulatori
role
sever
oligonucleotid
sequenc
taken
genom
motif
particularli
locat
gene
promot
use
potenti
aptam
thu
aid
comput
method
quadruplex
form
grich
sequenc
qgr
mapper
abl
identifi
sequenc
genom
basi
primari
sequenc
input
mani
potenti
aptam
act
decoy
molecul
develop
test
specif
protein
target
biolog
relev
ration
design
decoy
appear
promis
approach
anticanc
studi
likewis
rapid
progress
studi
site
epsteinbarr
viru
papilloma
viru
genom
particip
viral
life
cycl
facilit
develop
new
antivir
agent
genom
aptam
hope
test
near
futur
rel
low
number
aptam
present
approv
clinic
trial
might
leav
reader
impress
compound
repres
interest
biochem
tool
hold
poor
promis
real
therapeut
applic
howev
bear
mind
aptam
technolog
biomed
use
still
rel
young
sinc
underli
basic
knowledg
littl
year
old
henc
much
learn
fulli
master
tool
eventu
allow
matur
develop
aptamerbas
drug
nonetheless
exist
data
start
macugen
approv
drug
indic
research
field
particularli
area
properli
address
soon
bear
number
relev
concret
applic
furthermor
versatil
plastic
aptam
gquadruplex
form
fruit
exploit
variou
detect
assay
mani
analyt
method
make
use
thrombin
target
tba
proofofprincipl
propos
analyt
method
literatur
plenti
research
studi
develop
complic
multirecognit
system
rapid
easi
system
detect
thrombin
inde
almost
research
work
describ
new
tbabas
sens
system
author
claim
realiz
assay
potenti
extend
aptam
whatev
target
therefor
assay
select
detect
molecular
target
thrombin
use
aptam
expect
howev
critic
need
highresolut
structur
aptam
complex
target
fulli
answer
question
whether
tba
typic
atyp
aptam
afford
high
target
specif
bind
affin
display
tba
new
structur
help
aptam
meet
therapeut
promis
analyt
potenti
lead
new
chapter
dna
gquadruplex
research
transpar
document
associ
articl
found
onlin
version
